United States Patent	6,599,710
Faustman	July 29, 2003

---

Treatment of autoimmune disease 

Abstract

The present invention features a novel combination therapy useful in the treatment of autoimmune disease that increases or maintains the number of functional cells of a predetermined type in a mammal by killing or inactivating autoimmune cells and re-educating the host immune system.

---

Inventors:	Faustman; Denise (Weston, MA)
Assignee:	The General Hospital Corporation (Boston, MA)
Family ID:	26821843
Appl. No.:	09/521,064
Filed:	March 8, 2000

---

Current U.S. Class:	435/7.21; 435/7.24
Current CPC Class:	A61K 38/191 (20130101); A61K 39/08 (20130101); A61K 38/1774 (20130101); A61K 38/2006 (20130101); A61K 38/49 (20130101); A61K 35/39 (20130101); A61K 38/1774 (20130101); A61K 38/191 (20130101); A61K 35/39 (20130101); A61K 38/2006 (20130101); A61K 38/49 (20130101); A61K 2300/00 (20130101); A61K 2300/00 (20130101); A61K 2300/00 (20130101); A61K 2300/00 (20130101); A61K 2300/00 (20130101)
Current International Class:	A61K 38/49 (20060101); A61K 38/19 (20060101); A61K 39/08 (20060101); A61K 38/43 (20060101); G01N 033/567 (); G01N 033/53 ()